Oxford Nanopore Technologies (LON:ONT) Issues Quarterly Earnings Results

Oxford Nanopore Technologies (LON:ONT) posted its quarterly earnings results on Monday. The company reported GBX (15.10) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Oxford Nanopore Technologies had a negative net margin of 94.82% and a negative return on equity of 26.02%.

Oxford Nanopore Technologies Stock Performance

Shares of ONT stock opened at GBX 135.19 on Monday. The company’s fifty day moving average price is GBX 142.62 and its 200-day moving average price is GBX 148.42. The stock has a market cap of £1.31 billion, a PE ratio of -9.13 and a beta of 0.80. The company has a current ratio of 4.45, a quick ratio of 6.01 and a debt-to-equity ratio of 8.07. Oxford Nanopore Technologies has a 12 month low of GBX 88.60 and a 12 month high of GBX 224.80.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on ONT shares. Deutsche Bank Aktiengesellschaft upped their price target on shares of Oxford Nanopore Technologies from GBX 210 to GBX 225 and gave the company a “buy” rating in a report on Thursday, January 22nd. Royal Bank Of Canada upped their target price on Oxford Nanopore Technologies from GBX 280 to GBX 300 and gave the company an “outperform” rating in a report on Wednesday, January 21st. Peel Hunt reaffirmed a “hold” rating and issued a GBX 153 price target on shares of Oxford Nanopore Technologies in a research note on Friday, December 5th. Finally, Berenberg Bank restated a “buy” rating and issued a GBX 250 price objective on shares of Oxford Nanopore Technologies in a report on Thursday, January 22nd. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 233.60.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.